Phyto Extractions' RV Visits Retailers in Cross-Country Tour

July 8, 2021 7:00 AM

LANGLEY, BC / ACCESSWIRE / July 8, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™, "Phyto" or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™' is known for its iconic concentrate product - Shatter and brand success as it was built during the legacy or "grey"...

Read more

Viewpoint Molecular Targeting(R) Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

July 7, 2021 9:05 AM

Companies forge relationship to accelerate peptide drug discovery for next-generation radiopharmaceuticals Pepscan brings proprietary world-leading peptide drug discovery expertise and technologies Viewpoint to apply expertise in radiopharmaceuticals, chelation technologies and bioconjugate chemistry to accelerate the pace of discovery to clinic-ready radiopharmaceuticals CORALVILLE, IA / ACCESSWIRE / July 7, 2021 / Viewpoint...

Read more

RepliCel Applies for Manufacturing Approval for Its Collagen and Tissue Regeneration Cell Therapies

July 7, 2021 6:00 AM

Clinical development of RepliCel's skin rejuvenation and tendon regeneration injectables continues to meet milestones on path to commercialization in JapanVANCOUVER, BC / ACCESSWIRE / July 7, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FSE:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan's...

Read more

Liviana CBD Infused Extra Virgin Olive Oil E-Commerce Now Open for Business

July 6, 2021 9:00 AM

CAPE TOWN, SA / ACCESSWIRE / July 6, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its LivianaTM brand focused on creating premium CBD olive oils:LivianaTM is delighted to announce the opening of its e-commerce website. The website allows for easy and seamless...

Read more

FDA Grants Priority Review for Levo Therapeutics' New Drug Application for LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome

July 6, 2021 8:00 AM

CHICAGO, IL / ACCESSWIRE / July 6, 2021 / Levo Therapeutics, Inc., a biotechnology company dedicated to using genetic insights to advance treatments for Prader-Willi syndrome (PWS) and related disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for its New Drug Application (NDA) for LV-101 (intranasal carbetocin) as a treatment for hyperphagia and behavioral distress associated with PWS. FDA...

Read more

Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets

July 5, 2021 8:00 AM

KELOWNA, BC / ACCESSWIRE / July 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that on June 30, 2021 it made a request to voluntarily delist its common shares from the Canadian Securities Exchange (the “CSE”). It is expected that the close of business on Wednesday, July 7, 2021 will be the...

Read more

Fuse Science, Inc. Shareholder Update and Announcement of Kustomeroo

July 2, 2021 2:20 AM

JACKSONVILLE, FL / ACCESSWIRE / July 2, 2021 / Fuse Science, Inc.(OTC PINK:DROP), The company is pleased to announce Kustomeroo is coming as part of Fuse Science, Inc (DROP). David Delke founder of Kustomeroo will work to keep everyone updated via formal channels as well as Twitter @daviddelke, @kustomeroo and https://kustomeroo.com . The company will have an investor and shareholder event on Twitch https://www.twitch.tv/kustomeroo on Wednesday,...

Read more

Vitro Biopharma Inc. April 30, 2021; 2nd Quarter ended Financial Results of Operations and Shareholder Letter

July 1, 2021 3:00 PM

GOLDEN, CO / ACCESSWIRE / July 1, 2021 / Vitro Biopharma Inc. (formerly Vitro Diagnostics Inc.) (dba Vitro Biopharma), announced its quarter ended April 30, 2021, financial results of operations.Vitro Biopharma recorded record quarter ended April 30, 2021 revenues of $ 326,535 vs $128,632 an increase of 254% over the prior comparative quarter directly attributed to recovering from the COVID-19 pandemic. Revenues in the second quarter of 2021 of...

Read more

Black Bird Biotech, Inc. (BBBT) Announces Application to Uplist To OTCQB Venture Market

July 1, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / July 1, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that it has submitted its application to uplist to the OTCQB Venture Market. The company's management believes uplisting its common stock to the OTCQB will serve to improve the company's position in the public markets and substantially increase its visibility to a wider range of...

Read more

Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin

July 1, 2021 8:08 AM

Unprecedentedly Tiny, Uniform, and Stable Nanoemulsified Oil Droplets Containing Astaxanthin Expected to Significantly Increase Oral and Topical Absorption of this Antioxidant 6,000x More Powerful Than Vitamin CSOUTH EASTON, MA / ACCESSWIRE / July 1, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology...

Read more

Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management

June 30, 2021 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / June 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Heman Chao has notified the Board of Directors of the Company of his intention to step down from the position of Chief Executive Officer ("CEO"), Chief Scientific Officer ("CSO") and member of the Board,...

Read more

Thermic Science Receives its First North American Shipment of Thermic Infrared Heating Paint for Manufacturing the First Batch of North American Made Thermic Infrared Portable Heaters for Retail Consumer Sales and Distribution Across North America, Confirms ENDO/CSi-FR Acquisition

June 30, 2021 10:35 AM

NASHVILLE, TN / ACCESSWIRE / June 30, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097, OTC PINK:ENDO), is pleased to announce that the first shipment of the Thermic Infrared Heating Paint has cleared North American Customs and Border Services and has been recently received in North America to begin North American manufacturing of the advanced...

Read more

Viewpoint Molecular Targeting(R) Appoints Ewa Matczak MD, as Chief Medical Officer

June 30, 2021 10:00 AM

Medical oncologist specializing in hematology/oncology with 10 years of clinical and translational medicine research and 20 years of experience in early- and late-stage drug development at multiple leading global pharmaceutical companiesCORALVILLE, IA / ACCESSWIRE / June 30, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology...

Read more

International Stem Cell Corporation Announces Successful Completion of Its Phase 1 Clinical Trial in Parkinson's Disease

June 30, 2021 8:57 AM

CARLSBAD, CA / ACCESSWIRE / June 30, 2021 / International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today successful completion of its dose escalating phase 1 clinical trial (ClinicalTrials.gov Identifier: NCT02452723) evaluating the safety, tolerability and...

Read more

Applied UV Continues International Expansion with Airocide(R) Installation in Swiss International School

June 30, 2021 8:30 AM

Airocide® technology helps schools reopen and allow for the safe return to campusDistributor installation will serve as a prototype project for the expansion of the Airocide® solution into the school systems located in the EUMOUNT VERNON, NY / ACCESSWIRE / June 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light...

Read more

Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase

June 30, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer. The work the Company is contracting to conduct is intended to do pre-clinical...

Read more

Lexaria Announces 2021 Annual Meeting Results

June 29, 2021 4:05 PM

KELOWNA, BC / ACCESSWIRE / June 29, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the results of the 2021 Annual Meeting (the 'Meeting').On June 28, 2021 at 1:00 p.m. (Pacific Time), the Company held the Meeting whereby there were 2,735,413 shares of the Company represented in person or by proxy at the meeting, constituting 53.6% of the...

Read more

Wuhan Sciences Launches the M2Bio Surfboard NFT Collection

June 29, 2021 9:20 AM

CAPE TOWN, SA / ACCESSWIRE / June 29, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update:M2Bio Sciences is stepping into the realm of non-fungible tokens (NFTs) with their first NFT auction featuring 10 psychedelic M2Bio Surfboards. The artwork is inspired by their efforts of...

Read more

Newly Published Preclinical Data Highlight Broad Immune Activation of Mosaic ImmunoEngineering’s Lead Intratumoral Immunotherapy Candidate, MIE-101

June 29, 2021 7:00 AM

- Results Demonstrate Innate Immune System Activation Through Stimulation of Three Toll-Like Receptors (TLRs 2,4,7) -- MIE-101 Therapy Reduced Tumor Growth by 80% Compared to Tumors Treated with Agents Targeting TLRs 2 and 4 or TLR 7 Alone -NOVATO, CA / ACCESSWIRE / June 29, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on immunotherapies to treat and prevent...

Read more

Applied UV Announces Offering of Preferred Stock

June 28, 2021 8:00 AM

Proceeds to be used for general corporate purposes, including new investments and potential future acquisitionsMOUNT VERNON, NY / ACCESSWIRE / June 28, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly,...

Read more